Komori
Revision of earnings forecasts6092EnBio Holdings,IncInformation and Communications, Services and Others

Notice Regarding Differences Between Full-Year Consolidated Earnings Forecasts and Actual Results

For the fiscal year ending March 2026, full-year consolidated results were 1.3% below the previous forecast for net sales, while operating income, ordinary income, and net income attributable to owners of the parent exceeded the previous forecasts. The difference between the actual results and forecasts for the completed fiscal year is being reported.

Worth reading
55In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
165.1
%
Wording
Definitive
How definitive the wording is.

Revised forecast

Fiscal year ending March 2026 · Full yearPrevious forecast published Announced on 13 February 2026
Net Sales12,798→12,630million
-1.3%
Operating profit1,429→1,619million
+13.3%
Ordinary income1,321→1,598million
+21.0%
Profit attributable to owners of the parent100→265million
+165.1%
Net income per share12.35→32.73yen and sen
+165.0%

The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.

Reason for the revision

In the soil contamination remediation business, the cost ratios of projects completed at the end of the fiscal year improved more than assumed, while the period-end exchange rate remained at a weaker yen level than the assumed rate.

Previous-period resultsNet sales: ¥10,668 million; operating income: ¥839 million; ordinary income: ¥702 million; net income attributable to owners of the parent: ¥452 million; net income per share: ¥55.90 (full year ended March 2025)
Consolidated / non-consolidatedConsolidated
Revised forecast
ItemDetails
Net Sales¥12,798 million → ¥12,630 million(-1.3%)
Operating profit¥1,429 million → ¥1,619 million(+13.3%)
Ordinary income¥1,321 million → ¥1,598 million(+21.0%)
Profit attributable to owners of the parent¥100 million → ¥265 million(+165.1%)
Net income per share12.35 yen and sen → 32.73 yen and sen
Fiscal Period CoveredFiscal year ending March 2026
Period CoveredFull year
Publication date of previous forecastAnnounced on 13 February 2026
Previous-period resultsNet sales: ¥10,668 million; operating income: ¥839 million; ordinary income: ¥702 million; net income attributable to owners of the parent: ¥452 million; net income per share: ¥55.90 (full year ended March 2025)
Reason for the revisionIn the soil contamination remediation business, the cost ratios of projects completed at the end of the fiscal year improved more than assumed, while the period-end exchange rate remained at a weaker yen level than the assumed rate.
Consolidated / non-consolidatedConsolidated
Items this document does not state (2)
Details and amount of extraordinary lossDividend forecast revision

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

This was due to greater-than-expected improvement in the cost ratios of projects completed at the end of the fiscal year in the soil contamination remediation business, as well as the period-end exchange rate remaining at a weaker yen level than assumed.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Differences Between Full-Year Consolidated Earnings Forecasts and Actual Results | EnBio Holdings,Inc (6092) timely disclosure | Komori